₹584.35 56.05 (10.61%)
16:01 PM, 12-Mar-2025BSE : 540222
NSE : LAURUSLABS
Sector : Health care
ISIN Code : INE947Q01028
Last Updated: 12-Mar-2025 | 04:01 PM IST
Market Cap (₹ Cr) | 31,511 |
Traded Value (₹ Cr) | 2.59 |
Volume (Shares) | 44,335 |
Face Value (₹) | 2 |
52-Week High (₹) | 646.25 |
52-Week High Date | 07-Feb-2025 |
52-Week Low (₹) | 372.20 |
52-Week Low Date | 20-Mar-2024 |
All Time High (₹) | 723.55 |
All Time High Date | 12-Aug-2021 |
All Time Low (₹) | 59.60 |
All Time Low Date | 07-Aug-2019 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 31,511 |
EPS - TTM (₹) [C] | 3.71 |
P/E Ratio (X) [C] | 157.51 |
Face Value (₹) | 2 |
Latest Dividend (%) | 20.00 |
Latest Dividend Date | 06-Nov-2024 |
Dividend Yield (%) | 0.14 |
Book Value Share (₹) [C] | 76.66 |
P/B Ratio (₹) [C] | 7.62 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
SBI Large & Midcap Fund (IDCW) | 295.23 | 56,00,000 | 1.08 |
SBI Large & Midcap Fund (G) | 295.23 | 56,00,000 | 1.08 |
SBI Large & Midcap Fund - Direct (G) | 295.23 | 56,00,000 | 1.08 |
SBI Large & Midcap Fund - Direct (IDCW) | 295.23 | 56,00,000 | 1.08 |
Franklin India Prima Fund - (G) | 98.71 | 18,72,358 | 0.93 |
Franklin India Prima Fund - Direct (G) | 98.71 | 18,72,358 | 0.93 |
SBI Healthcare Opportunities Fund (IDCW) | 89.62 | 17,00,000 | 2.71 |
SBI Healthcare Opportunities Fund (G) | 89.62 | 17,00,000 | 2.71 |
SBI Healthcare Opportunities Fund - Direct (G) | 89.62 | 17,00,000 | 2.71 |
SBI Healthcare Opportunities Fund - Direct (IDCW) | 89.62 | 17,00,000 | 2.71 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High (₹) | 563.35 585.60 |
Week Low/High (₹) | 324.25 585.60 |
Month Low/High (₹) | 324.25 585.60 |
Year Low/High (₹) | 372.20 646.00 |
All time Low/High (₹) | 59.60 724.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 70.94% | 70.94% | 22.97% | 27.64% |
1 Month | 54.69% | 54.67% | 19.03% | 23.24% |
3 Month | 22.31% | 22.26% | 19.93% | 24.47% |
6 Month | 11.83% | 11.89% | 25.04% | 29.23% |
1 Year | 9.68% | 9.68% | 24.11% | 27.96% |
3 Year | 578.45% | 580.03% | 82.98% | 91.93% |
Executive Director & CEO : CHAVA SATYANARAYANA
Executive Director & CFO : VENKATA RAVI KUMAR VANTARAM
Executive Director : Chandrakanth Chereddi
Director : Narendra Ostawal
Independent Director : Aruna Bhinge
Independent Director : Rajesh Koshy Chandy
Independent Director : Ramesh Subrahmanian
Company Secretary : G Venkateswar Reddy
Chairman : M Venu Gopala Rao
Independent Director : Ravindranath Kancherla
Executive Director : Venkata Lakshmana Rao Chunduru
Registered Office: Plot No 21 Jawaharlal Nehru, Pharma City Parawada,Visakhapatnam,Andhra Pradesh-531021 Ph: 91-891-3061222
1. What's the Laurus Labs Ltd share price today?
Laurus Labs Ltd share price was Rs 584.35 at 16:01 PM IST on 12th Mar 2025. Laurus Labs Ltd share price was up by 10.61% over the previous closing price of Rs 528.30. Laurus Labs Ltd share price trend:
2. How can I quickly analyse the performance of the Laurus Labs Ltd stock?
The performance of the Laurus Labs Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Laurus Labs Ltd?
Laurus Labs Ltd has a market capitalisation of Rs 31,511 crore.
4. What is Laurus Labs Ltd's 52-week high/low share price?
The Laurus Labs Ltd’s 52-week high share price is Rs 646.25 and 52-week low share price is Rs 372.20.
5. Is the Laurus Labs Ltd profitable?
On a consolidated basis, Laurus Labs Ltd reported a profit of Rs 57.27 crore on a total income of Rs 1,272.31 crore for the quarter ended 2024. For the year ended Dec 2024, Laurus Labs Ltd had posted a profit of Rs 90.61 crore on a total income of Rs 1,424.47 crore.
6. Which are Laurus Labs Ltd’s peers in the Health care sector?
Laurus Labs Ltd’s top 5 peers in the Health care sector are Biocon, Ipca Labs., Ajanta Pharma, Laurus Labs, Suven Pharma, Piramal Pharma, Gland Pharma.
7. Who owns how much in Laurus Labs Ltd?
Key changes to the Laurus Labs Ltd shareholding are as follows: